Apellis Pharmaceuticals shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Apellis Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Apellis Pharmaceuticals held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Apellis Pharmaceuticals by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $7.2M | 180k | 40.23 |
| 2025-12-31 | $4.5M | 179k | 25.12 |
| 2025-09-30 | $3.8M | 168k | 22.63 |
| 2025-06-30 | $5.2M | 302k | 17.31 |
| 2025-03-31 | $4.9M | 223k | 21.87 |
| 2024-12-31 | $6.8M | 213k | 31.91 |
| 2024-09-30 | $5.5M | 191k | 28.84 |
| 2024-06-30 | $8.0M | 208k | 38.36 |
| 2024-03-31 | $8.2M | 139k | 58.78 |
| 2023-12-31 | $8.5M | 142k | 59.86 |
| 2023-09-30 | $5.6M | 146k | 38.04 |
| 2023-06-30 | $6.6M | 100k | 65.96 |
| 2023-03-31 | $6.6M | 100k | 65.96 |
| 2022-12-31 | $3.9M | 75k | 51.71 |
| 2022-09-30 | $4.7M | 69k | 68.30 |
| 2022-06-30 | $16M | 352k | 45.22 |
| 2022-03-31 | $20M | 390k | 50.81 |
| 2021-12-31 | $18M | 374k | 47.28 |
| 2021-09-30 | $6.7M | 204k | 32.96 |
| 2021-06-30 | $13M | 213k | 63.20 |
| 2021-03-31 | $2.4M | 56k | 42.91 |
| 2020-12-31 | $2.0M | 67k | 30.17 |
| 2020-09-30 | $2.0M | 67k | 30.17 |
| 2020-06-30 | $2.1M | 65k | 32.66 |
| 2020-03-31 | $1.3M | 47k | 26.79 |
| 2019-12-31 | $1.1M | 36k | 30.62 |
| 2019-09-30 | $776k | 32k | 24.09 |
| 2019-06-30 | $353k | 14k | 25.34 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas